Today: 29 April 2026
Dow Jones today: DJIA edges up near 49,000 as AI spending scrutiny deepens
29 January 2026
2 mins read

Dow Jones today: DJIA edges up near 49,000 as AI spending scrutiny deepens

New York, January 29, 2026, 10:01 EST — Regular session

  • In early trading, the Dow edged up roughly 0.1%, hovering close to 49,000
  • Big Tech earnings spotlight AI investments and margin pressures
  • Traders are focused on Apple’s earnings report due Thursday, with inflation figures set for Friday.

The Dow Jones Industrial Average edged higher by 47.89 points, or 0.10%, reaching 49,063.49 by 9:45 a.m. ET, after fluctuating between 48,938.27 and 49,292.81. The S&P 500 dropped 0.35%, while the Nasdaq slid 0.93%.

The tension is clear: investors tolerate hefty capital spending—“capex,” the funds companies funnel into chips, data centers, and gear—only if sales keep pace. “The market appears to be questioning whether these massive capital expenditure hikes will generate sufficient returns,” said Jesse Cohen, senior analyst at Investing.com. Reuters

Wednesday saw the Dow finish almost unchanged after the Federal Reserve kept its benchmark rate steady at 3.50%-3.75%, offering scant hints on when borrowing costs might drop next. “Whether you were bullish or bearish … you walked away feeling about the same,” said Michael James, an equity sales trader at Rosenblatt Securities. Reuters

Dow components diverged after the close. Microsoft shares fell in after-hours trading following a warning about record AI-related expenses. Meanwhile, IBM surged after beating quarterly estimates, thanks to strong demand for AI-driven software. “One big obvious issue is that revenues are up 17% and the cost of revenues are up 19%,” noted Eric Clark, portfolio manager of the LOGO ETF, which includes Microsoft. Reuters

New labor figures kept the tone “steady but not great.” Initial jobless claims dropped to 209,000 last week, though the previous week’s numbers were revised higher. Continuing claims slid to 1.827 million, suggesting hiring still holds firm. With a January 30 funding deadline approaching, there’s growing concern about further delays in U.S. economic data, including next week’s employment report, Reuters said. Reuters

The macro backdrop showed cracks. The U.S. trade deficit nearly doubled in November, jumping 94.6% to $56.8 billion as imports spiked. Capital goods like computers and semiconductors drove the surge, a trend tied to the AI investment boom, the report noted. Economists cautioned this could lead to cuts in fourth-quarter growth forecasts.

The Dow is price-weighted, so stocks with higher prices have a bigger impact on the index than their market caps might imply. This setup can make the benchmark react sharply to earnings moves in just a few components.

The risk remains tangible. Should AI spending outpace profit growth, investors might continue to push valuations higher — particularly if interest rates linger at elevated levels and economic data trickle in sporadically or with delay.

Apple is set to report after the close, with analysts forecasting its strongest iPhone sales growth in over four years. Total revenue is expected to hit a record $138.43 billion. Investors will be paying close attention to any remarks on costs and supply issues amid tightening memory chip markets. Gerrit Smit, manager of the Stonehage Fleming Global Best Ideas Equity fund, noted, “Apple can probably generate a positive return on very little AI investment, thanks to its distribution.” Reuters

Friday at 8:30 a.m. ET brings the December producer price index, a key gauge for pipeline inflation. Traders will watch closely to see if it hints at the Federal Reserve’s next steps this year.

Stock Market Today

  • CDE vs. AUGO: Evaluating Mining Stocks for 2026 Upside Potential
    April 29, 2026, 10:20 AM EDT. Coeur Mining (CDE) and Aura Minerals (AUGO) face a volatile precious metals market shaped by high gold and silver prices and economic uncertainty. CDE expects robust 2026 production, led by its Rochester and Las Chispas mines, and benefits from recent acquisitions including SilverCrest Metals and its pending deal for New Gold Inc. This expands its high-grade asset base and diversifies its portfolio. Aura Minerals leverages Latin American assets to grow production and reserves, underpinned by disciplined capital spending. Both focus on cost control and operational efficiency amid inflation and price swings. CDE's financial strength with over $550 million in cash provides a buffer for expansion, while AUGO's diversified pipeline supports sustainable growth. Investors must weigh growth potential against market risks when choosing between these miners.

Latest article

Generac Stock Jumps After Data Center Backlog Forces a 2026 Forecast Reset

Generac Stock Jumps After Data Center Backlog Forces a 2026 Forecast Reset

29 April 2026
Generac Holdings raised its 2026 sales outlook after first-quarter net sales rose 12% and commercial and industrial sales jumped 28% to $510 million, driven by data center demand. Shares climbed 11% after adjusted earnings of $1.80 a share beat estimates. The company now expects full-year net sales growth in the mid-to-high teens percentage range, up from its prior forecast. Generac also increased its adjusted EBITDA margin guidance.
Lemonade Stock Jumps as Q1 Revenue Surge Sharpens Its 2026 Profit Test

Lemonade Stock Jumps as Q1 Revenue Surge Sharpens Its 2026 Profit Test

29 April 2026
Lemonade Inc reported first-quarter revenue of $258 million, up 71% from a year earlier, and narrowed its net loss to $35.8 million, or 47 cents a share. Shares rose 5.6% in premarket trading after results beat estimates. In-force premium climbed 32% to $1.33 billion, with customers up 23% to 3.14 million. The company raised its 2026 outlook and now expects full-year revenue of up to $1.203 billion.
Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Biogen lowered its 2026 adjusted earnings forecast to $14.25–$15.25 per share, citing research and development charges from recent acquisitions. First-quarter revenue rose 2% to $2.48 billion, with adjusted earnings of $3.57 per share, beating analyst estimates. Leqembi sales climbed 74% to $168 million globally.
AMD stock slides as Big Tech’s AI spending boom meets fresh nerves on Wall Street
Previous Story

AMD stock slides as Big Tech’s AI spending boom meets fresh nerves on Wall Street

Eli Lilly stock price today: LLY rises on $1.93 billion Repertoire deal as earnings near
Next Story

Eli Lilly stock price today: LLY rises on $1.93 billion Repertoire deal as earnings near

Go toTop